# Sodium-Glucose Co-transporter-2 Inhibitor of Dapagliflozin Attenuates Myocardial Ischemia/Reperfusion Injury by Limiting NLRP3 Inflammasome Activation and Modulating Autophagy

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/sodium-glucose-co-transporter-2-inhibitor-of-dapagliflozin-attenuates-myocardial/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Yongwei Yu,Jiaqun Que,Shuai Liu,Kaiyu Huang,Qian Lu,Yingbei Weng,Fangning Rong,Lei Wang,Yingying Zhou,Yangjing Xue,Kangting Ji |
| Citations | 114 |
| DOI | 10.3389/fcvm.2021.768214 |
| Fields | Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://doi.org/10.3389/fcvm.2021.768214 |
| OpenAlex ID | https://openalex.org/W4206183782 |
| PMID | 35083298 |
| Type | article |
| Year | 2022 |

## Paper authors

- [Kaiyu Huang](https://scholariq.org/researchers/kaiyu-huang/)

## Paper journal

- [Frontiers in Cardiovascular Medicine](https://scholariq.org/journals/frontiers-in-cardiovascular-medicine/)

## Paper primary topic

- [Autophagy in Disease and Therapy](https://scholariq.org/topics/autophagy-in-disease-and-therapy/)

## Paper topics

- [Autophagy in Disease and Therapy](https://scholariq.org/topics/autophagy-in-disease-and-therapy/)
- [Pancreatic function and diabetes](https://scholariq.org/topics/pancreatic-function-and-diabetes/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.